Breaking News

GE Opens ‘Factory-in-a-Box’ for Viral Vector Production

New factory-in-a-box accelerates the production of viral vector-based therapeutics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector-based therapeutics, including viral vector-based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio biomanufacturing facility is designed, constructed, assembled and fully fitted-out to current good manufacturing practice (cGMP) standards significantly faster than is required to build a traditional, stick-built manufacturing facility. This makes it ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters